Loading market data...
Latest Top News
Show more
Sun Pharma’s Organon Bid Sparks Credit Shift: Moody’s Ratings Under Review For Upgrade
In a major pharma shake-up, Moody's has placed Organon's ratings under review for an upgrade following Sun Pharma's proposed $2.7 billion acquisition, signaling strong strategic growth potential for both firms.
Stay Ahead – Explore Now! Rashmika Mandanna’s ‘Mysaa’ Embarks On 15-Day Kerala Shoot Packed With High-Octane Action Sequences






